Novo Nordisk’s bid to provide a once-weekly basal insulin product for people with diabetes, reducing the number of injections needed, has hit a major hurdle in the US. The FDA sent the Danish ...
The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...
The places where you inject insulin may depend on the type of syringe or prefilled insulin pen you use. You should rotate these injection sites on your skin each time you inject insulin.
Novo Nordisk Development executive vice-president Martin Holst Lange stated: “We believe that by reducing the number of basal insulin injections from seven to one per week, Awiqlihas the ...
insulin icodec would reduce the number of basal insulin injections needed per year for type 2 diabetics from 365 to 52, a significant reduction in disease burden. The lower injection frequency ...
compared the efficacy and safety of a basal-bolus insulin regimen with that of sliding-scale regular insulin (SSI) in hospitalized general medical patients with type 2 diabetes. The prospective ...
Awiqli, a weekly insulin injection, will soon become available in Canada, which doctors say will 'make life easier' for ...
Dexcom (Nadsaq:DXCM) announced today that it launched a new multi-region report evaluating type 2 diabetes treatments.
Brazil's National Health Surveillance Agency (Anvisa) has approved the drug Awiqli, produced by the pharmaceutical company ...
NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results